• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ CELL PREPARATION TUBE WITH SODIUM CITRATE; LYMPHOCYTE SEPARATION MEDIUM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON, DICKINSON & CO. (BROKEN BOW) BD VACUTAINER® CPT¿ CELL PREPARATION TUBE WITH SODIUM CITRATE; LYMPHOCYTE SEPARATION MEDIUM Back to Search Results
Catalog Number 362761
Medical Device Problem Code Incorrect, Inadequate or Imprecise Result or Readings (1535)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/02/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported while using bd vacutainer® cpt¿ cell preparation tube with sodium citrate an unspecified number of samples exhibited poor barrier separation and the gel consistency was not always firm (could be gooey or stringy).There was no health impact or consequences reported.
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d9: device available for evaluation: yes.H3: device eval by manufacturer? yes.D9: returned to manufacturer on: 07-apr-2025.Investigation summary: bd received six samples and five photos for investigation.The returned samples were visually inspected with no issues identified.Visual evaluation of the returned photos showed the presence of poor barrier separation.The photos show the gel is on the sidewall of the tube after the tube was centrifuged but does not show incorrect gel consistency.Additionally, 60 retained samples were also visually inspected with no issues identified.Complaints for sample quality are under statistical control for the month of april 2025.At this time, further testing is not indicated.Based on a review of the device history record for the incident lot, all product specifications and requirements for lot release were met.This complaint has been confirmed for the indicated failure mode: poor barrier separation.This complaint has not been confirmed for the indicated failure mode: additive abnormality(gel consistency issue).No definitive root cause could be established for the reported defects.Complaints received for this device and reported condition will continue to be tracked and trended.Information will be captured on trend reports and monitored.Our business team regularly reviews the collected data for the identification of emerging trends.Bd quality will continue to monitor sample quality complaints.
 
Event or Problem Description
It was reported while using bd vacutainer® cpt¿ cell preparation tube with sodium citrate an unspecified number of samples exhibited poor barrier separation and the gel consistency was not always firm (could be gooey or stringy).There was no health impact or consequences reported.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD VACUTAINER® CPT¿ CELL PREPARATION TUBE WITH SODIUM CITRATE
Common Device Name
LYMPHOCYTE SEPARATION MEDIUM
Manufacturer (Section D)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer (Section G)
BECTON, DICKINSON & CO. (BROKEN BOW)
150 south 1st avenue
broken bow NE 68822
Manufacturer Contact
matt j. connor
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key21936959
Report Number1917413-2025-00546
Device Sequence Number7985183
Product Code JCF
UDI-Device Identifier30382903627616
UDI-Public(01)30382903627616(11)240918(17)250930(10)4262290
Combination Product (Y/N)N
Initial Reporter StateOK
Initial Reporter CountryUS
PMA/510(K) Number
NA
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 05/29/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Expiration Date09/30/2025
Device Catalogue Number362761
Device Lot Number4262290
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/07/2025
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 04/02/2025
Supplement Date Received by Manufacturer05/29/2025
Initial Report FDA Received Date04/30/2025
Supplement Report FDA Received Date06/26/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/18/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-